Project Grant HT94252310705
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The federal Project Grant award in the amount of $435,876.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public, with a particular emphasis on conditions relevant to military personnel and veterans. The award will fund research conducted by Temple University-Of The...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
This Defense Health Agency (DHA) Project Grant award for $4,509,475.00, granted on Sep 15, 2023 under the Military Medical Research and Development program (CFDA 12.420), supports a 4-year research project titled "Optimizing a Surveillance Strategy to Tackle Breast Cancer Dormancy and Minimal Residual Disease" to be conducted by the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The objective of this research is...
The U.S. Department of the Army Medical Command awarded a $1,585,000 federal Project Grant to Temple University-Of The Commonwealth System Of Higher Education under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective March 1, 2025 through February 28, 2029, will fund research to target lymphatic chemokine signaling and promote lymphangiogenesis for the treatment of lymphedema. This research initiative aims to transform healthcare for military service members...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $325,000 project grant to The Trustees of the University of Pennsylvania (Penn) to develop a PET agent, (18F-THA), for studying the central and intestinal lymphatic system. The 2-year project, with a performance period from April 15, 2024 to April 14, 2026, aims to advance research on the lymphatic system, which is relevant to military medical priorities. As a renowned research...
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
The U.S. Department of Defense's Defense Health Agency awarded a $752,000 Project Grant to The Institute For Cancer Research, a subsidiary of Temple University, to investigate therapeutic response disparities in locally advanced rectal cancer. This grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative and impactful research....
This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) program, provides $1,178,136.00 to The Trustees of the University of Pennsylvania (Clinical Practices of the University of Pennsylvania) to conduct research on exploiting the absence of TP53 mutations in epithelial ovarian cancer using next-generation p53-stabilizing agents. The research project aims to develop innovative therapeutic approaches for this type of...
This $390,000 Formula Grant award under the Military Medical Research and Development (CFDA 12.420) program, administered by the Defense Health Agency, supports research by The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to exploit synthetic essential genetic dependencies in order to define oncogenic signaling networks and establish novel targets for the treatment of lung adenocarcinoma. The award, with a performance...
The U.S. Defense Health Agency awarded a $831,658 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project investigating "GUT-BRAIN MECHANISMS OF IMPROVING HEALTH IN AN ANIMAL MODEL OF SCI FOLLOWING WEIGHT LOSS SURGERY". As a leading academic medical center, Penn State has a track record of delivering...